Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

Regeneron Leverages its Technology Platform, Process and People in the Hopes of Having A COVID-19 Therapy in Trials by Summer

Regeneron and its “VELOCISUITE®” platform was used to develop a treatment for Ebola (REGN-EB3), currently used by the Congolese government to fight that horrific virus. The New York State-based venture has, like many biopharma companies, dedicated a full force operation to target COVID-19. In a 24X7 operation, the company reports “sleepless nights” and “headway” toward a potential vaccine. After initiating hundreds of virus-neutralizing antibodies, they have declared public plans to initiate large-scale manufacturing by mid-April with antibody cocktail therapy with the potential to commence human clinical trials by early summer.

In addition to collaborating with Sanofi (a French pharmaceutical company) to repurpose a drug (Kevzara®) that could address conditions experienced by COVID-19 patients, the company appears to be making notable progress in its mission to find a vaccine for the novel coronavirus. TrialSite News breaks down this information, offered by Regeneron via their press release, so that hopefully more people can have a better understanding of the current situation.

Who heads up their COVID-19 R&D?

Christos Kyratsous, PhD, Vice Preside...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee